JEFFREY REYES: Open Payments
NPI 1811016710 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 11 payments from 7 companies in 2025. Trend: 2023 $1,461 · 2024 $1,064 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 3 | $380 |
| SCPHARMACEUTICALS INC. | 2 | $247 |
| Sequel Med Tech, LLC | 1 | $157 |
| AstraZeneca Pharmaceuticals LP | 2 | $149 |
| Mirum Pharmaceuticals, Inc. | 1 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $123 |
Products named: HyperRAB, FUROSCIX, TWIIST, Livmarli, Gamunex-C, WAINUA, Auvelity.
Industry payments across NY — which companies pay providers there.
